Stay updated with breaking news from Daniel Drucker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The success of semaglutide mimic drugs in helping people lose weight saw demand rocket in 2023, with manufacturers struggling to keep up - something that almost never happens
Press release – No. 16 / 2023 Zealand Pharma to highlight obesity pipeline at R&D Event on December 5 Event to be hosted by company management and feature key external scientific and clinical experts
CBC's Marketplace rounds up the consumer and health news you need from the week.
Despite widely publicized reports of rare but severe side effects, obesity doctors say Ozempic and drugs like it have the potential to vastly medical help for a chronic illness that patients have been forced for too long to try to cure on their own.
New data also shows a reduced rate of cardiovascular problems in some patients